Study	Reason for exclusion
Alloussi 1998a	No usable data in abstract
Andersen 1987	No usable data in abstract
Appell 1997	A meta‐analysis of 4 studies. Trials not reported separately. Not all trials placebo‐controlled.
Baert 1995	Abstract. Means reported for incontinent episodes and voids per day but no meausures of variability, need more information from authors
Brocklehurst 1972	A study in the elderly with no evidence presented that the participants had overactive bladders.
Burgio 1994	No usable data in abstract
Cardozo 2005	Outcome reported was warning time which was not an inclusion criteria of the review
Chapple 2001	No usable data in abstract
Chapple 2002	No usable data in abstract
Chapple 2003	No usable data in abstract
Chapple 2004	No usable data in abstract
Chapple 2005a	A pooled analysis of three studies. Trials not reported separately
Coombes 1994	This study has two parallel designs with one side randomised and other non‐randomised
Davila 2001a	Comparison of oral + placebo versus transdermal + placebo
Di Stasi 2001b	RCT. Excluded as intravesical administration.
Dorschner 2003b	The extracted data reported in percentage and hence not usable for analysis
Gerstenberg 1986	Terodiline has been withdrawn from therapeutic useworldwide
Goode 2004	Data reported as percentage improvement. No medians or means reported.
Griebenow 1994	A randomised trial of propiverine versus placebo. Only outcome dysrhythmia on ECG.
Kirschner‐Hermanns	A study in the elderly with no evidence presented that the participants had overactive bladders
Kuipers 2002	No usable data in abstract
Larsson 1999	A meta‐analysis of 4 studies Trials not reported separately Some studies published separately
Norton 1994	Terodiline withdrwan from therapeutic use worldwide
Ouslander 1995	A study in the elderly with no evidence presented that the participants had overactive bladders
Robinson 1983	Emepronium bromide with flavoxate hydrochloride versus placebo. Excluded as active therapy includes flavoxate
Rosario 1999	Crossover trial with darifenacin versus placebo. Principle outcomes are comparison of ambulatory versus conventional cystometry
Rudy 2004	No usable data in abstract
Smith 2002	No usable data in abstract
Staskin 2004	This study reported on somnolence and sleepiness in patients with overactive bladder
Takayasu 1990 1	The data reported as percentage and hence not usable for analysis
Tapp 1987	Terodiline has been withdrawn from therapeutic useworldwide
Tapp 1989	Terodiline has been withdrawn from therapeutic useworldwide
Terodiline 1993	Terodiline has been withdrawn from therapeutic useworldwide
Viayna 2004	RCT. Healthy male volunteers with no mention of overactive bladder symptoms or urinary incontinence at baseline. Aim of study to evaluate safety and tolerability of an antimuscarinic.
Wagg 2003	This randomised trail compares urodynamic findings in retrospect from a previous report with hypothesis that anticholinergics change at the onset and end of urinary flow with anticholinergics
Wein 1999	A meta‐analysis of 2 studies Trials not reported separately
Whitehead 1967	A study in the elderly with no evidence presented that the participants had overactive bladders
Williams 1981	A study in the elderly with no evidence presented that the participants had overactive bladders